• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC BAKRI TAMPONADE BALLOON CATHETER; OQY INTRAUTERINE TAMPONADE BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC BAKRI TAMPONADE BALLOON CATHETER; OQY INTRAUTERINE TAMPONADE BALLOON Back to Search Results
Model Number G30673
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/04/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H3: device evaluation is anticipated but not yet begun.This report includes information known at this time.A follow up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
As reported, following a cesarean delivery, a 'bakri tamponade balloon catheter' was to be used for treatment of postpartum hemorrhage (pph) secondary to uterine atony.The patient experienced an estimated blood loss of 400 ml.Before placing the balloon, the inner and outer packaging was inspected prior to use and found to be intact.Prior to use, balloon integrity was tested by injecting saline solution with leaking noted from the balloon.The user replaced the device with a similar one to complete the procedure and hemostasis was achieved.The total estimated blood loss was 500 ml.The patient did not require any blood transfusions.The patient did not require any additional intervention due to this occurrence.The patient did not experience any adverse effects due to this occurrence.
 
Additional Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Investigation ¿ evaluation.As reported, following a cesarean delivery, a 'bakri tamponade balloon catheter' was to be used for treatment of postpartum hemorrhage (pph) secondary to uterine atony.The patient experienced an estimated blood loss of 400 ml.Before placing the balloon, the inner and outer packaging was inspected prior to use and found to be intact.Prior to use, balloon integrity was tested by injecting saline solution with leaking noted from the balloon.The user replaced the device with a similar one to complete the procedure and hemostasis was achieved.The total estimated blood loss was 500 ml.The patient did not require any blood transfusions.The patient did not require any additional intervention due to this occurrence.The patient did not experience any adverse effects due to this occurrence.A visual inspection of the returned device was conducted.A document based investigation was also performed including a review of complaint history, device history record (dhr), instructions for use (ifu), manufacturer¿s instructions (mi), and quality control (qc) procedures.One device was returned for investigation in inner protective packaging without label.A "t" shaped puncture was seen in the balloon material.No tool marks were present.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.A review of the device history record (dhr) found no related non-conformances reported for this failure mode.A complaint history database search showed one other related complaint associated with the failure mode for the complaint device lot.Due to the individual nature of the manufacturing and inspection process for the devices in the lots, it is unlikely that these events are an indication of device issue within the entire lot.Because there are no related non-conformances, adequate inspection activities have been established, there is objective evidence that the dhr was fully executed, it was concluded that there is no evidence that nonconforming product exists in house or in the field.Cook also reviewed product labeling; the ifu supplied with the device states the following in consideration of the reported failure mode: how supplied "upon removal from the package, inspect the product to ensure no damage has occurred." based upon the available information, inspection of the returned device, and results of the investigation, cook has concluded that the cause for the complaint could not be established.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints per the risk assessment, no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAKRI TAMPONADE BALLOON CATHETER
Common Device Name
OQY INTRAUTERINE TAMPONADE BALLOON
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer (Section G)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
jason crouch
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key22335517
Report Number1820334-2025-00778
Device Sequence Number9129104
Product Code OQY
UDI-Device Identifier10827002306735
UDI-Public(01)10827002306735(17)271105(30)1(10)16326619
Combination Product (Y/N)N
Initial Reporter CountryCN
PMA/510(K) Number
K170622
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Distributor
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberG30673
Device Catalogue NumberJ-SOS-100500
Device Lot Number16326619
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/09/2025
Supplement Date Received by Manufacturer07/25/2025
Initial Report FDA Received Date06/26/2025
Supplement Report FDA Received Date08/12/2025
Date Device Manufactured11/05/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age30 YR
Patient SexFemale
Patient Weight61 KG
-
-